1、Science For A Better LifeAnnual Report 2005Bayer Group Key DataBayer Annual Report 2005Bayer Group20042005Change million%Net sales23,27827,383+17.6EBITDA13,8344,647+21.2Operating result EBIT1,8752,812+50.0Income before income taxes1,2222,199+80.0Net income 6851,597+133.1Earnings per share20.942.19+1
2、33.1Gross cash fl ow32,8853,477+20.5Net cash fl ow42,2623,542+56.6Stockholders equity(total,i.e.including discontinued operations)10,94311,157+2.0Total assets(total,i.e.including discontinued operations)37,58836,722 2.3Debt/equity ratio(total,i.e.including discontinued operations)2.432.29 5.9Capital
3、 expenditures9771,388+42.1Employees at year end91,70093,700+2.2Personnel expenses6,0265,912 1.9Research and development expenses1,9271,886 2.1Bayer AG20042005Change%Total dividend payment in million402694+72.6Dividend per share in 0.550.95+72.61 ebitda=operating result(ebit)plus depreciation and amo
4、rtization2 Earnings per share=as defi ned in ias 33:net income divided by the average number of shares outstanding(730.34 million shares)3 Gross cash fl ow=operating result(ebit)plus depreciation and amortization,minus income taxes,minus gains/plus losses on retirements of noncurrent assets,plus/min
5、us changes in pension provisions.The latter item includes the elimination of non-cash components of the operating result.It also contains benefi t payments during the year.4 Net cash fl ow=cash fl ow from operating activities according to ias 7Ten-Year Financial SummaryBayer Annual Report 2005Bayer
6、Group19961997199819992000 millionNet sales 24,85328,12428,06227,32030,971Sales outside Germany82.2%83.9%83.6%84.3%85.6%Share of foreign consolidated companies65.4%67.0%67.5%68.3%69.0%Operating result(EBIT)2,3063,0773,1553,3573,287Income(loss)before income taxes2,2822,6112,7282,8362,990Income(loss)af